Yuanzi Yu - Concepedia

Author

Yuanzi Yu

Chinese PLA General Hospital

Also Known As

Yuan-Zi Yu, Yuan-zi Yu, Yuanzi Yu

Publications

273

Citations

H-Index

Concepts

All Affiliations

Chinese PLA General Hospital Shandong Provincial Hospital Sidney Kimmel Comprehensive Cancer Center Nankai University Shandong University

About

Yuanzi Yu is an author at Chinese PLA General Hospital specializing in cancer research, pathology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	153
2	Cell Biology	3	3	153
3	Pathology	3	3	153
4	Cancer Cell Biology	2	2	90
5	Cancer Genetics	2	2	90

Yuanzi Yu

Publications

261

Citations

H-Index

Page 1

	Year	Citations
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer Yan Jia, Yunsheng Yang, Qimin Zhan, Journal of Molecular Diagnostics Esophageal CancerPathologyMicrorna 141Wnt Signaling PathwayMicrorna Detection	2012	63
SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer. Dongtao Yin, Yan Jia, Yuanzi Yu, PubMed Tumor BiologyOncologyOncogenic AgentMedicineSox17 Methylation	2012	48
DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling. Yuanzi Yu, Wenji Yan, Xuefeng Liu, PubMed PathologyHuman Gastric CancerCancer BiologyEpigeneticsTumor Biology	2014	42
Methylation of <i>TFPI-2</i> is an Early Event of Esophageal Carcinogenesis Yan Jia, Yunsheng Yang, Malcolm V. Brock, Epigenomics	2012	40
AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer Yuanzi Yu, Dongtao Yin, Mohammad Obaidul Hoque, Tumor Biology	2011	20
PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma Tao Li, Yuanzi Yu, Juan Liu, Infectious Agents and Cancer	2019	20
Overexpression of Numb suppresses growth, migration, and invasion of human clear cell renal cell carcinoma cells Jin Sima, Zhang Bao, Yuanzi Yu, Tumor Biology	2014	18
Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine–oxaliplatin versus short-course radiotherapy followed by capecitabine–oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial Feng Tian, Honghai Dai, Dan Sha, The Lancet Oncology	2025	10

Page 1